Liming Chen
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Liver Disease and Transplantation 3
- Co-authors
- Liangliang Dong (1 shared paper)Weimin Wang (1 shared paper)Tong‐Yin Zhu (4 shared papers)Xiaobo Yu (1 shared paper)Haijun Guo (1 shared paper)Yuan‐Chi Su (1 shared paper)Fei Chen (1 shared paper)Wu Zhang (1 shared paper)
- Journals
- Swarm and Evolutionary Computation (2 papers)Coronary Artery Disease (2 papers)Signal Transduction and Targeted Therapy (1 paper)Biomarkers in Medicine (1 paper)Supportive Care in Cancer (1 paper)
- Partner nations
- ChinaMadagascarHong Kong
In The Last Decade
Liming Chen
45 papers receiving 385 citations
Peers
Comparison fields: 5 of 65
- Hepatology 60
- Cancer Research 107
- Endocrinology 14
- Molecular Biology 117
- Oncology 39
Countries citing papers authored by Liming Chen
This map shows the geographic impact of Liming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Chen more than expected).
Fields of papers citing papers by Liming Chen
This network shows the impact of papers produced by Liming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Chen. The network helps show where Liming Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 71 | |
| 2 | 2018 | 48 | |
| 3 | 2015 | 37 | |
| 4 | 2024 | 24 | |
| 5 | 2009 | 20 | |
| 6 | 2023 | 19 | |
| 7 | Identification of Escherichia coli O157:H7 by multiplex PCR with primers specific to the hlyA, eaeA, stx1, stx2, fliC and rfb genes. | 2002 | 16 |
| 8 | 2011 | 12 | |
| 9 | Influence of chronic kidney disease on the outcome of patients with chronic total occlusion. | 2016 | 11 |
| 10 | 2021 | 11 | |
| 11 | 2015 | 11 | |
| 12 | 2017 | 10 | |
| 13 | 2016 | 8 | |
| 14 | 2018 | 8 | |
| 15 | 2020 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2020 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2020 | 5 | |
| 20 | Cytological and molecular identification of cytoplasm in two male sterile lines in radish. | 2009 | 4 |
About Liming Chen
Liming Chen is a scholar working on Hepatology, Cancer Research, Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Molecular Biology, having authored 49 papers that have together received 389 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease and Transplantation (3 papers), Genomics and Phylogenetic Studies (2 papers), Traditional Chinese Medicine Studies (2 papers), Advanced Multi-Objective Optimization Algorithms (2 papers), Metaheuristic Optimization Algorithms Research (2 papers), Influenza Virus Research Studies (2 papers) and Medicinal Plant Pharmacodynamics Research (2 papers). The work is most often cited by research in Hepatology (60 citations), Cancer Research (107 citations), Endocrinology (14 citations), Molecular Biology (117 citations) and Oncology (39 citations). Liming Chen has collaborated with scholars based in China, Madagascar and Hong Kong. Frequent co-authors include Liangliang Dong, Weimin Wang, Tong‐Yin Zhu, Xiaobo Yu, Haijun Guo, Yuan‐Chi Su, Fei Chen, Wu Zhang, Shusen Zheng and Junhui Sun. Their work appears in journals such as Swarm and Evolutionary Computation, Coronary Artery Disease, Signal Transduction and Targeted Therapy, Biomarkers in Medicine and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.